MedPath
FDA Approval

Granisetron hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Natco Pharma Limited
DUNS: 650224736
Effective Date
October 25, 2019
Labeling Type
Human Prescription Drug Label
Granisetron(1 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Natco Pharma Limited-Pharma Division

Natco Pharma Limited

918588174

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Granisetron hydrochloride

Product Details

NDC Product Code
63850-0005
Application Number
ANDA078969
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 25, 2019
Code: 318F6L70J8Class: ACTIMQuantity: 1 mg in 1 1
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
© Copyright 2025. All Rights Reserved by MedPath